Bg pattern

NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

NovoThirteen 2,500UI powder and solvent for solution for injection

catridecacog (recombinant coagulation factor XIII)

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is NovoThirteen and what is it used for
  2. What you need to know before you use NovoThirteen
  3. How to use NovoThirteen
  4. Possible side effects
  5. Storage of NovoThirteen
  6. Contents of the pack and other information

1. What is NovoThirteen and what is it used for

What is NovoThirteen

NovoThirteen contains the active substance catridecacog, which is identical to human coagulation factor XIII, an enzyme necessary for blood coagulation. NovoThirteen replaces the missing factor XIII and promotes the stabilization of the initial blood clot by creating a mesh around it.

What is NovoThirteen used for

NovoThirteen is used to prevent bleeding in patients who do not have enough or are missing part of factor XIII (called subunit A).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use NovoThirteen

It is important that you use NovoThirteen solution for injection immediately after preparation.

Do not use NovoThirteen

  • If you are allergic to catridecacog or any of the other ingredients of this medicine (listed in section 6).

If you are not sure, consult your doctor before using this medicine.

Warnings and precautions

Consult your doctor before starting treatment with NovoThirteen:

  • If you have or have had a higher risk of blood clot formation (thrombosis), as NovoThirteen may increase the severity of a pre-existing blood clot.
  • If you have or have had any liver injury.

Contact your doctor immediately:

  • If you experience bleeding during treatment with NovoThirteen and it occurs spontaneously and/or requires treatment.
  • If you experience an allergic reaction to NovoThirteen. Symptoms may include: hives, itching, swelling, difficulty breathing, low blood pressure (symptoms include paleness and cold skin, rapid pulse), dizziness, and sweating.

Other medicines and NovoThirteen

Tell your doctor if you are using, have recently used, or might use any other medicines.

It is not recommended to use NovoThirteen in combination with recombinant coagulation factor VIIa (another blood coagulation factor).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.

NovoThirteen contains sodium

This medicine contains less than 23 mg (1 mmol) of sodium per injection, so it is essentially "sodium-free".

3. How to use NovoThirteen

Your treatment with NovoThirteen should be started by a doctor with experience in the treatment of rare bleeding disorders.

Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, consult your doctor again.

Before using NovoThirteen for injection, you need to reconstitute the product. See the instructions for use of NovoThirteen.

NovoThirteen is administered intravenously. The dose will depend on your body weight. The usual dose for preventing bleeding is 35 UI per kilogram of body weight. Injections are given once a month (every 28 ± 2 days).

If you experience bleeding, you should contact your doctor who will decide if you need an injection.

NovoThirteen should be injected at a rate not exceeding 2 ml/minute.

According to the concentration of the NovoThirteen solution, the dose volume for injection (in milliliters) can be calculated using the following formula:

Dose volume in milliliters = 0.042 x your body weight in kilograms.

You should only use the dose prescribed and calculated by your doctor using this formula, taking into account that the usual dose and concentration of NovoThirteen are different from those of other medicines containing factor XIII.

Your doctor may adjust the dose if necessary.

Use in small children

For children who weigh less than 24 kg, reconstituted NovoThirteen should be further diluted with 6 ml of 0.9% sodium chloride solution for injection to adjust the dose for small children. See the section "Instructions for use of NovoThirteen - Instructions on how to dilute reconstituted NovoThirteen" for more information.

The dose volume for reconstituted NovoThirteen diluted with 6 ml of 0.9% sodium chloride solution for injection can be calculated using the following formula:

Dose volume in milliliters = 0.117 x body weight in kilograms.

Use in children and adolescents (who weigh more than 24 kg)

NovoThirteen can be used in adolescents and children in the same way as in adults, both for the prevention of bleeding and if bleeding occurs.

If you use more NovoThirteen than you should

Information on overdose of NovoThirteen is limited. None of the reported cases have shown symptoms of illness. Contact your doctor if you have injected a larger amount of NovoThirteen than indicated.

If you forget to use NovoThirteen

Consult your doctor if you forget to take a NovoThirteen injection. Do not use a double dose to make up for forgotten doses.

If you stop using NovoThirteen

If you stop using NovoThirteen, you will no longer be protected against bleeding. Do not stop using NovoThirteen without consulting your doctor, who will explain the consequences of stopping treatment and offer you other options.

If you have any other questions about the use of this medicine, ask your doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Side effects include:

Common:(may affect up to 1 in 10 people):

  • Headache (the most common side effect)
  • Pain at the injection site
  • Pain in legs and arms
  • Increased amount of small protein fragments due to the dissolution of blood clots
  • Decreased number of some types of white blood cells. This means that your body may be more prone to infections
  • Development of antibodies against factor XIII. These antibodies do not affect the effect of the medicine.

Side effects in children:

The side effects seen in children are the same as those seen in adults, but side effects may be more frequent in children than in adults.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of NovoThirteen

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date is the last day of the month stated.

Store in a refrigerator (between 2°C and 8°C).

Do not freeze.

Store in the original package to protect from light.

Once prepared, NovoThirteen for injection should be used immediately.

The solution is clear and colorless. Do not use this medicine if you notice particles or a change in color when reconstituted.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

Composition of NovoThirteen

  • The active substance is catridecacog (recombinant coagulation factor XIII): 2,500 UI/3 ml, after reconstitution, corresponding to a concentration of 833 UI/ml.
  • The other ingredients are, for the powder: sodium chloride, sucrose, and polysorbate 20, L-histidine, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment), and for the solvent: water for injections.

Appearance of the product and pack contents

NovoThirteen is supplied as a powder and solvent for solution for injection (2,500 UI of powder in a vial and 3.2 ml of solvent in a vial, with a vial adapter).

Pack size of 1.

The powder is white and the solvent is clear and colorless.

Marketing authorisation holder and manufacturer

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

Denmark

Date of last revision of this leaflet:

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.

Instructions for use of NovoThirteen

To reconstitute and administer this medicine, you will need the following materials: a 10 ml syringe or a syringe of suitable size according to the injection volume, alcohol swabs, the vial adapter included, and an infusion set (tubing, butterfly needle).

Mathematical formula that calculates volume with body weight in kilograms and initial dose in milligrams

Preparation of the solution

Always use aseptic technique. Before starting, wash your hands. Bring the powder and solvent vials to a temperature not above 25°C, keeping the vials in your hands until you feel they are at the same temperature as your hands. Remove the plastic caps from the 2 vials. Do not use the vials if the caps are loose or missing. Clean the rubber stoppers of the vials with an alcohol swab and let them dry before use.

Hand placing a cotton swab soaked with liquid over the injection site on the skin, gently pressing with the fingers

The medicine is reconstituted using the included vial adapter.

Remove the paper seal from the vial adapter without removing it from the protective cap. Place the vial adapter on the solvent vial (water for injections). Be careful not to touch the spike of the vial adapter.

Once attached, remove the protective cap from the vial adapter.

Hand holding an auto-injector with an arrow indicating the direction of injection into the skin

Pull the syringe plunger to draw up a volume of air equivalent to the total amount of solvent contained in the solvent vial.

Hands holding a pre-filled injection device connecting an applicator with an arrow indicating rotation

Screw the syringe firmly onto the vial adapter attached to the solvent vial. Inject air into the vial by pushing the plunger until you feel a clear resistance.

Hand holding a transparent syringe with a gray plunger and a black arrow pointing downwards indicating pressure

Hold the syringe with the solvent vial upside down. Pull the plunger to draw up the solvent and transfer it to the syringe.

Hand holding an auto-injector with a black arrow indicating the direction of insertion into the skin fold

Remove the empty solvent vial by tilting the syringe attached to the vial adapter.

Hand holding an auto-injector with an arrow indicating the direction of injection and a transparent vial connected

Adjust the vial adapter, still attached to the syringe, onto the powder vial until you hear a click. Hold the syringe slightly tilted with the vial downwards. Slowly push the plunger to inject the solvent into the powder vial. Make sure not to direct the jet of solvent directly onto the powder as this would create foam.

Vial of medicine with powder and pre-filled syringe being prepared for administration by rotating the vial

Make gentle circular movements with the vial until all the powder is dissolved. Do not shake the vial, as this would create foam.

NovoThirteen should be inspected visually for particulate matter and discoloration prior to administration. If either is observed, discard the medicine.

Reconstituted NovoThirteen is a clear and colorless solution.

If a larger dose is needed, repeat the procedure in a separate syringe until the required dose is reached.

Important information

Once prepared, NovoThirteen for injection should be used immediately.

If dilution of reconstituted NovoThirteen is needed, refer to the section "Dilution of reconstituted product with 0.9% sodium chloride solution for injection".

Hand holding a transparent syringe with a gray plunger and a black arrow pointing downwards indicating pressure

Make sure the plunger is pushed all the way down before turning the syringe (it may have been expelled by the pressure in the vial). Hold the syringe with the vial upside down and pull the plunger to draw up the calculated amount for the injection.

Hands holding a syringe connected to a transparent vial turning to insert the needle and withdraw the medicine

Unscrew the vial adapter with the vial.

The medicine is now ready to be injected into a vein. Follow the injection procedure as instructed by your doctor.

After injection

Syringe with needle connected to a vial and two additional vials with their caps near a circular container with radial lines and a black arrow

Discard the syringe, vial adapter, infusion set, and vials safely. Disposal of unused medicine and all materials that have come into contact with it should be done according to local regulations.

Instructions on how to dilute reconstituted NovoThirteen

To dilute reconstituted NovoThirteen, you will need the following materials: a vial containing 0.9% sodium chloride solution for injection, a 10 ml syringe, and alcohol swabs.

General instructions for dilution

Dilution should be carried out using aseptic techniques.

Carefully draw up exactly 6 ml of 0.9% sodium chloride solution for injection into the 10 ml syringe.

Slowly inject the 6 ml of 0.9% sodium chloride solution for injection into the vial of reconstituted NovoThirteen.

Make gentle circular movements with the vial to mix the solution.

The diluted solution is a clear and colorless solution. Check the solution for particles and discoloration. If you notice either, please discard it.

After dissolution, proceed to step H.

Any residual material from the diluted product should be discarded immediately.

If you have any doubts, ask your doctor or nurse.

Online doctors for NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Discuss questions about NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
The active ingredient in NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is catridecacog. This information helps identify medicines with the same composition but different brand names.
Who manufactures NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is manufactured by Novo Nordisk A/S. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to NOVOTHIRTEEN 2500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION?
Other medicines with the same active substance (catridecacog) include ADVATE 1,000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION, ADVATE 1500 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION, ADVATE 1000 IU POWDER AND SOLVENT FOR INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media